Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies defense contractors, aerospace and industrial customers. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Littleton, Massachusetts.…
Precision Optics (POCI) Q1 2027 Earnings Call Transcript
Precision Optics (NASDAQ: POCI) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 108 employees.
The shares were at 4.120 USD on 20 November 2026, down 1.2% over 52 weeks. Its 52-week range is 3.550 USD to 6.150 USD: the price is 33.0% below the high and 16.1% above the low.
Its market capitalisation is 45.30M USD.
Precision Optics reports return on equity of -17.8%, an operating margin of -7.4% and revenue up 22.0% year over year.
It holds more cash than debt, a net cash position of 5.13M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 8.000 USD is 94.2% above the current price. The next earnings report is expected on 15 February 2027.